These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 1196876
1. [Plasma half-life of cefazoline. Study in the normal subject and in the patient with renal insufficiency]. Humbert G, Fillastre JP, Leroy A. Nouv Presse Med; 1975 Oct 18; 4(35):2523-6. PubMed ID: 1196876 [No Abstract] [Full Text] [Related]
3. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance]. Malandain H, Humbert G, Fillastre JP, Acar J, Dubois D, Leroy J, Robert M, Daufresne MF. Pathol Biol (Paris); 1973 Mar 18; 21(3):233-9. PubMed ID: 4574486 [No Abstract] [Full Text] [Related]
4. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity]. Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J. Arzneimittelforschung; 1974 Sep 18; 24(9b):1491-7. PubMed ID: 4479810 [No Abstract] [Full Text] [Related]
5. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics]. Nissenson AR, Levin NW, Parker RH. Arzneimittelforschung; 1974 Sep 18; 24(9b):1470-3. PubMed ID: 4479806 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics and bioavailability of cefazolin in horses. Sams RA, Ruoff WW. Am J Vet Res; 1985 Feb 18; 46(2):348-52. PubMed ID: 3994100 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients. Leroy A, Canonne MA, Fillastre JP, Humbert G. Curr Ther Res Clin Exp; 1974 Sep 18; 16(9):878-89. PubMed ID: 4214662 [No Abstract] [Full Text] [Related]
11. Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency. Craig WA, Welling PG, Jackson TC, Kunin CM. J Infect Dis; 1973 Oct 18; 128():Suppl:S347-5. PubMed ID: 4744016 [No Abstract] [Full Text] [Related]
12. Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment. Kuypers D, Vanwalleghem J, Maes B, Messiaen T, Vanrenterghem Y, Peetermans WE. Nephrol Dial Transplant; 1999 Aug 18; 14(8):2050-1. PubMed ID: 10462306 [No Abstract] [Full Text] [Related]
16. Study of the serum half-life of a new cephalosporin in uraemic patients. Fillastre JP, Humbert G, Acar J, Malandain H, Robert M, Dubois D, Daufresne MF. Proc Eur Dial Transplant Assoc; 1972 Jan 01; 9():577-80. PubMed ID: 4668933 [No Abstract] [Full Text] [Related]
17. Effect of hemodialysis on cefazolin protein binding. Greene DS, Tice AD. J Pharm Sci; 1977 Oct 01; 66(10):1508-10. PubMed ID: 925922 [No Abstract] [Full Text] [Related]
19. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity]. Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J. Pathol Biol (Paris); 1973 Jun 01; 21(6):671-9. PubMed ID: 4581199 [No Abstract] [Full Text] [Related]